SweetBio
PrivateLast Round
VC Round
May 28, 2025
Total Funding Raised
$4.35M
Company Overview
SweetBio operates in Healthcare & Life Sciences and is based in Memphis, Tennessee. Its latest recorded funding round was a VC Round in May 2025.
SweetBio is a biotechnology company that develops honey-incorporated absorbable membranes designed to provide advanced wound care treatments.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SweetBio Comparables
Compare SweetBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RenovoDerm | 87% | |
| Imbed Biosciences | 86% | |
| Brightwake Ltd | 79% |
For institutional investors. Book with your work email.
SweetBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 28, 2025 | ||||
| VC Round | Aug 26, 2021 | ||||
| Seed | Feb 8, 2019 | ||||
| Seed | Jun 13, 2016 | ||||
| Seed | Dec 1, 2015 | ||||
Accelerator | Aug 13, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SweetBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The JumpFund | Seed |
| DEMI Fund | VC Round |
| MB Venture Partners | Seed, Accelerator |
| 1945 Capital | VC Round |
| Innova Memphis | Seed, Accelerator |
| VamosVentures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors grew 104% MoM, reaching 1.3K.
- May 20, 2026
Monthly visitors increased 362% from 134 to 619.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 1, 2026
SweetBio Inc. and Hartmann Group partner through an exclusive national commercial distribution agreement that expands clinician and patient access across the United States to VERIS, an advanced wound care product, on Oct 1st '26 in South Carolina.
For institutional investors. Book with your work email.
SweetBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SweetBio's valuation, stock price, and market status.
Is SweetBio a public or private company?
SweetBio is a private company.
What is the current stock price of SweetBio?
SweetBio is a private company, so its shares have no public market price. Caplight tracks SweetBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SweetBio worth (valuation)?
Valuation information for SweetBio is not publicly available.
Can I buy SweetBio stock?
SweetBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SweetBio's last funding round?
SweetBio's most recent funding round was VC Round on May 28, 2025.
Who are the main investors in SweetBio?
Key investors in SweetBio include The JumpFund, DEMI Fund, MB Venture Partners, 1945 Capital, Innova Memphis.
Will SweetBio IPO soon?
No public IPO plans have been announced for SweetBio.
How can I track SweetBio secondary market activity?
Caplight tracks bids, offers, and trades in SweetBio's shares on secondary markets.